Episode 169

The Basics of Treating Hepatitis C

CorConsult Rx: Evidence-Based Medicine and Pharmacy · Mike Corvino, PharmD, BCACP, BCPS, CDCES and Cole Swanson, PharmD, CDCES

January 28, 202243m 56s

Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Original episode page

Show Notes

On this episode, we discuss some of the basics of treating a patient with hepatitis C. We list the labs that should be drawn prior to starting treatment as well as non-invasive ways of assessing fibrosis/cirrhosis. We also review some information about the pangenotypic medications, Epclusa and Mavyret.

Click the following link to see the upcoming events from the Southeast Viral Hepatitis Interactive Case Confirmation (SVICC): https://www.seaetc.com/

Thanks for listening!

If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

Mike - [email protected] Cole - [email protected]

Instagram and other social media platforms - @corconsultrx

This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

← All episodes of CorConsult Rx: Evidence-Based Medicine and Pharmacy